Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells

72Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

To identify cancer-specific targets, we have conducted a synthetic lethal screen using a small interfering RNA (siRNA) library targeting ∼4,000 individual genes for enhanced killing in the DLD-1 colon carcinoma cell line that expresses an activated copy of the K-Ras oncogene. We found that siRNAs targeting baculoviral inhibitor of apoptosis repeat-containing 5 (survivin) significantly reduced the survival of activated K-Ras-transformed cells compared with its normal isogenic counterpart in which the mutant K-Ras gene had been disrupted (DKS-8). In addition, survivin siRNA induced a transient G2-M arrest and marked polyploidy that was associated with increased caspase-3 activation in the activated K-Ras cells. These results indicate that tumors expressing the activated K-Ras oncogene may be particularly sensitive to inhibitors of the survivin protein. Copyright © 2007 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Sarthy, A. V., Morgan-Lappe, S. E., Zakula, D., Vernetti, L., Schurdak, M., Packer, J. C. L., … Fesik, S. W. (2007). Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells. Molecular Cancer Therapeutics, 6(1), 269–276. https://doi.org/10.1158/1535-7163.MCT-06-0560

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free